![Kate Kostelyk, IgA nephropathy (IgAN) patient, and her labrador Dakoda in Mims, Florida Kate Kostelyk, IgA nephropathy (IgAN) patient, and her labrador Dakoda in Mims, Florida](/sites/novartis_com/files/styles/cta_image/public/2025-01/portrait-of-kate-kostelyk-and-her-labrador.jpg.webp?itok=F9aGVCCm)
Novartis in Society Integrated Report 2024
The Novartis in Society Integrated Report covers our business, strategy and performance. It highlights progress against our ESG targets and describes how we create value for diverse stakeholders.
![A female health worker talking a male patient through his medication steps and holding a bottle of pills in her hand. A female health worker talking a male patient through his medication steps and holding a bottle of pills in her hand.](/sites/novartis_com/files/styles/cta_image/public/2023-11/lp-esg-media-content-investor-update.jpg.webp?itok=4Dm3gyFb)
Impact & Health Equity Update 2024
Our 11th annual ESG investor event provided updates on the impact we continue to deliver through inclusive access to innovation, environmental sustainability, and resilient operations, all while ensuring compliance to ESG reporting requirements.
View the event presentation (PDF 1.9 MB)
For more recent progress, we provide a quarterly impact and sustainability update.
Q4 2024 Impact and Sustainability Update (PDF 1.0 MB)
Q3 2024 Impact and Sustainability Update (PDF 0.6 MB)
Q2 2024 Impact and Sustainability Update (PDF 0.9 MB)
Q1 2024 Impact and Sustainability Update (PDF 1.4 MB)
ESG strategic priorities
Building trust with society is a key part of the Novartis corporate strategy and is critical to delivering on our purpose of reimagining medicine to improve and extend people’s lives. Our ESG efforts are integrated across the company and are key to driving long-term sustainable value for our stakeholders.
We believe our inspired, curious and unbossed culture will drive better performance. ESG topics form a core component of how the Novartis Executive Committee and the Board of Directors evaluate long-term performance of the company. We are committed to reporting transparently on these topics through our Reporting and Transparency Hub, which includes the Novartis in Society Integrated Report (PDF 5.0 MB), as well as our other publications.
![Doctor in Rwanda weighing a baby Doctor in Rwanda weighing a baby](/sites/novartis_com/files/styles/cta_image/public/2023-01/doctor-weighing-baby-rwanda.jpg.webp?itok=HTX2owUq)
Access
We are committed to expanding access to our medicines globally, working with our partners.
![People walking seen from above People walking seen from above](/sites/novartis_com/files/styles/cards_1_3/public/2021-10/people-walking-taken-from-above.jpg.webp?itok=wtKOdh7v)
Ethics, Risk and Compliance
To meet the expectations society has of our industry, we strive to maintain high ethical standards, manage risk effectively and ensure we comply with applicable laws and regulations.
![Trees seen from below Trees seen from below](/sites/novartis_com/files/styles/cards_1_3/public/2021-09/view-of-the-sky-through-trees-in-a-forest.jpg.webp?itok=aJx1oMK3)
Environmental Sustainability
We understand the link between the health of our planet and the health of our patients. We are making progress in reducing the environmental impact of our operations in line with our near- and long-term targets.
![Portrait of Elon Mathieson Portrait of Elon Mathieson](/sites/novartis_com/files/styles/cards_1_3/public/2023-11/elon-mathieson-portrait2.jpg.webp?itok=ieTTr-SJ)
Inclusion
We foster an inclusive culture, believing it fuels innovation, drives engagement, and attracts talent.
We aim to conduct business responsibly wherever we operate with a focus on building a strong ethical foundation, respect for human rights, patient health and safety, inclusion and the safety and well-being of our employees. We have clear commitments on many other social topics including the living wage, product quality and use of animals in research.
Corporate governance
Our corporate governance framework supports sustainable financial performance and long-term value creation and is aligned with our values and behaviors. In a rapidly changing business environment, we apply effective risk management to build resilience. We continue taking important steps to integrate our ESG agenda into the core of our business, enhancing executive accountability and measuring our performance against transparent targets. Members of the Executive Committee and other senior leaders have ESG targets in their annual objectives.
Transparent reporting
Transparent reporting has been a central part of our commitment for many years and we continue to make progress in this area.
![People relaxing in the Novartis Basel campus People relaxing in the Novartis Basel campus](/sites/novartis_com/files/styles/cta_image/public/2021-10/esg-index-people-sitting-in-a-small-square.jpg.webp?itok=J5eHjyft)
Environmental, Social and Governance (ESG) Index
Novartis aims to report comprehensively and transparently about ESG topics. We have created a set of environmental, social and governance indices to signpost where our key disclosures can be found across our publications and channels.
![Prof. Dr. Ulf Landmesser (center) at the Charité hospital in Berlin, Germany Prof. Dr. Ulf Landmesser (center) at the Charité hospital in Berlin, Germany](/sites/novartis_com/files/styles/cards_50_50/public/2025-01/prof-dr-ulf-landmesser-at-charite-hospital-berlin-germany.jpg.webp?itok=Kk1_Hnan)
Reporting and transparency hub
Read our regulatory filings; policies, codes and guidelines that govern our activities; and environmental, social and governance (ESG) disclosures.
![Business people in a meeting Business people in a meeting](/sites/novartis_com/files/styles/cards_50_50/public/2021-10/thandwisa-hero.jpg.webp?itok=Hlaug9nS)
Positions on key topics
As part of our ongoing commitment to transparency, we state our position on key issues affecting our business and of specific interest to our stakeholders.
![Three business people discussing on Novartis campus Three business people discussing on Novartis campus](/sites/novartis_com/files/styles/cards_50_50/public/2021-10/three-business-people-discussion-on-novartis-compus.jpg.webp?itok=c66-yd3n)
Awards & recognition
Novartis is honored to receive numerous awards for progress in research and development, our working environment, and our ESG activities.
![People walking on Novartis Campus People walking on Novartis Campus](/sites/novartis_com/files/styles/cards_50_50/public/2021-10/people-walking-down-novartis-basel-campus.jpg.webp?itok=9aJRbanr)
ESG rating performance
Our performance against environmental, social and governance criteria is reflected in a variety of third-party ratings.
![K Malesh, a farmer in the village of Sollakpally, now has ready access to water to irrigate his crops. K Malesh, a farmer in the village of Sollakpally, now has ready access to water to irrigate his crops.](/sites/novartis_com/files/styles/cta_image/public/2024-01/k-malesh-farmer-in-sollakpally-has-access-to-water.jpg.webp?itok=qUghlWiG)
Water project revives rural community in India
Novartis is aiming for water neutrality in our own operations by 2030. In India, we are contributing to this goal through a project near Hyderabad with a nonprofit organization. By tackling both water scarcity and the deprivation it causes, the project has revived the community.
![Sister Martine, a trained nurse, dispensing medicine at the Catholic mission’s health center in Ntui, Cameroon. Sister Martine, a trained nurse, dispensing medicine at the Catholic mission’s health center in Ntui, Cameroon.](/sites/novartis_com/files/styles/cta_image/public/2024-01/a-partnership-against-epilepsy.jpg.webp?itok=QRweRjOV)
A partnership against epilepsy
Parts of Cameroon have rates of epilepsy that are among the highest in the world. Despite the availability of effective therapies, poverty, a lack of medical resources and superstition about the causes of epilepsy often lead to inadequate treatment and social exclusion for people living with the neurological condition. Novartis is working with a Catholic mission on the ground in a central part of the country to overcome these barriers and improve care.